JPS6113184B2 - - Google Patents
Info
- Publication number
- JPS6113184B2 JPS6113184B2 JP5860178A JP5860178A JPS6113184B2 JP S6113184 B2 JPS6113184 B2 JP S6113184B2 JP 5860178 A JP5860178 A JP 5860178A JP 5860178 A JP5860178 A JP 5860178A JP S6113184 B2 JPS6113184 B2 JP S6113184B2
- Authority
- JP
- Japan
- Prior art keywords
- haptoglobin
- hemoglobin
- immobilized
- kit
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108010054147 Hemoglobins Proteins 0.000 claims description 27
- 102000001554 Hemoglobins Human genes 0.000 claims description 27
- 102000014702 Haptoglobin Human genes 0.000 claims description 24
- 108050005077 Haptoglobin Proteins 0.000 claims description 24
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 description 19
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 9
- 238000005259 measurement Methods 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- 239000011521 glass Substances 0.000 description 6
- 210000002381 plasma Anatomy 0.000 description 6
- 229920002678 cellulose Polymers 0.000 description 5
- 239000001913 cellulose Substances 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 229920005654 Sephadex Polymers 0.000 description 4
- 239000012507 Sephadex™ Substances 0.000 description 4
- 229920002684 Sepharose Polymers 0.000 description 4
- 238000011088 calibration curve Methods 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 206010018910 Haemolysis Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 230000008588 hemolysis Effects 0.000 description 3
- 239000000123 paper Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 108010071602 haptoglobin-hemoglobin complex Proteins 0.000 description 2
- 229920006158 high molecular weight polymer Polymers 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 150000001282 organosilanes Chemical class 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 239000005373 porous glass Substances 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 1
- JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical group OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 229930182556 Polyacetal Natural products 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- GRWZHXKQBITJKP-UHFFFAOYSA-L dithionite(2-) Chemical compound [O-]S(=O)S([O-])=O GRWZHXKQBITJKP-UHFFFAOYSA-L 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 201000001505 hemoglobinuria Diseases 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000002210 silicon-based material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Description
【発明の詳細な説明】
生体で溶血が起ると血漿中に遊離したヘモグロ
ビンは、ハプトグロビンと結合して肝臓へ運ば
れ、そこにおいて代謝されて鉄は再利用される。DETAILED DESCRIPTION OF THE INVENTION When hemolysis occurs in a living body, hemoglobin liberated in plasma is combined with haptoglobin and transported to the liver, where it is metabolized and iron is recycled.
しかし、高度の溶血を伴うような疾患や外傷の
際には血漿ハプトグロビンは消費し尽され過剰の
遊離ヘモグロビンは遊離のまま体内を循環し1部
は尿中に排出される。従つて臨床において血中や
尿中の遊離ヘモグロビンを測定することは重要な
意義を有する。 However, in the event of a disease or trauma accompanied by a high degree of hemolysis, plasma haptoglobin is exhausted and excess free hemoglobin circulates in the body as a free substance, with a portion being excreted in the urine. Therefore, measuring free hemoglobin in blood and urine has important clinical significance.
一方、高度の溶血を伴い血色素尿症や乏尿を呈
する患者にハプトグロビン製剤を注射してこれを
治療あるいは予防しようとするとき血漿中の遊離
メモグロビンやヘモグロビン−ハプトグロビン複
合体の量、あるいは尿中ヘモグロビン量を測定す
ることは大切である。 On the other hand, when injecting a haptoglobin preparation into a patient who presents with hemoglobinuria or oliguria due to severe hemolysis, the amount of free memoglobin or hemoglobin-haptoglobin complex in the plasma, or the amount of hemoglobin in the urine is measured. It is important to measure quantities.
ヘモグロビンの測定は、これまではシアンメト
ヘモグロビン法、ベンジジン法およびハイドロサ
ルフアイト法等の吸光度法で行なわれているが、
遊離ヘモグロビンとヘモグロビン−ハプトグロビ
ン複合体のヘモグロビンとを分別して定量するこ
とはできず、その上測定結果を得るまでに時間を
要した。 Until now, hemoglobin has been measured using absorbance methods such as the cyanmethemoglobin method, benzidine method, and hydrosulfite method.
It was not possible to separate and quantify free hemoglobin and hemoglobin in the hemoglobin-haptoglobin complex, and furthermore, it took time to obtain measurement results.
本発明は、固定化したハプトグロビンを用い
て、検体中の遊離ヘモグロビンを捕集し、捕集さ
れたヘモグロビン量を求めることにより簡単且つ
迅速に分別定量する方法からなる。 The present invention consists of a method for simply and quickly performing differential quantification by collecting free hemoglobin in a specimen using immobilized haptoglobin and determining the amount of collected hemoglobin.
本発明で使用するハプトグロビン(以下Hpと
いうこともある)は、その由来を特に限定される
ものではなく哺乳動物等のHpのように多量に回
収できるものであればよい。 The origin of the haptoglobin (hereinafter sometimes referred to as Hp) used in the present invention is not particularly limited, as long as it can be recovered in large quantities, such as Hp from mammals.
Hpを固定化する担体は、一般に酵素など活性
タンパク質の不溶化法として知られる特開昭51−
105186号に詳記される。 The carrier for immobilizing Hp is generally used as a method for insolubilizing active proteins such as enzymes.
Detailed in No. 105186.
即ち、従来実施又は提案されている酵素の不溶
化方法としては、高分子多糖体を臭化シアンで活
性化させたものに酵素を結合させるとか、ケイ素
材料に酵素を共有結合させるなど不溶性担体に化
学的に結合させる方法(特開昭46−1838号)、活
性炭吸着などの物理的(米国特許第2717852号)
若しくは塩基性陰イオン交換体に吸着させるなど
の静電的(特公昭45−6870号)な方法、適当なマ
トリツクス、例えばフイブリン重合体中に酵素を
埋没させる方法(特開昭49−41584号)などが挙
げられ、本発明に用いられる不溶化ハプトグロビ
ンの製造は、酵素の代りに上記の精製されたハプ
トグロビンを用いること以外は同じ方法によつて
達せられる。 In other words, conventionally implemented or proposed methods for insolubilizing enzymes include bonding the enzyme to a polymeric polysaccharide activated with cyanogen bromide, or covalently bonding the enzyme to a silicon material. Physical methods such as activated carbon adsorption (US Pat. No. 2,717,852)
Alternatively, an electrostatic method such as adsorption to a basic anion exchanger (Japanese Patent Publication No. 45-6870), or a method of embedding the enzyme in a suitable matrix such as fibrin polymer (Japanese Patent Publication No. 49-41584) The insolubilized haptoglobin used in the present invention can be produced by the same method except that the purified haptoglobin described above is used instead of the enzyme.
ハプトグロビンを化学的に結合させて不溶化す
るために用いられる担体は、ハプトグロビンと結
合可能な基、例えばカルボキシル基又はアミノ基
などを有する水不溶性有機又は無機高分子材料で
ある。例えばポリアクリルアミドゲル〔バイオ−
ゲル(Bio−gel)P 300など:米国、バイオゲ
ル社発売〕、アガロース〔セフアロース
(Sepharose)4Bなど:スウエーデン国、フアル
マシア社発売〕、デキストラン〔セフアデツクス
(Sephadex)G200、DEAE−セフアデツクス
(DEAE−Sephadex)、QAE−セフアデツクス
(QAE−Sephadex)など:スウエーデン国、フ
アルマシア社発売〕、更にはセルローズ(DEAE
−セルロース、CM−セルロース、AE−セルロ
ースなど)のようなハプトグロビンと直接結合し
ない多糖体で、これらを臭化シアンで処理するこ
とにより結合能を与えた材料が有利に用いられ
る。多糖類を臭化シアンで処理する方法はP.アト
レカサス及びC.B.アンフインセン
(Cuatrecasas、P.and Anfinsen、C.B.)〔メソー
ズ イン エンザイモロジイ 、ジヤコビ
編(Methods in Enzymology.、ed、by
Jakoby、W.B.)pp345、(1971)〕によつて提案
されているアフイニテイークロマトグラフイーの
手法でタンパクを(不溶化)する方法として既に
確立されている。 The carrier used to chemically bind and insolubilize haptoglobin is a water-insoluble organic or inorganic polymeric material having a group capable of binding to haptoglobin, such as a carboxyl group or an amino group. For example, polyacrylamide gel [Bio-
Gel (Bio-gel) P 300, etc.: Released by Bio-gel, USA], Agarose (Sepharose 4B, etc.: Released by Pharmacia, Sweden), Dextran [Sephadex G200, DEAE-Sephadex] , QAE-Sephadex (marketed by Pharmacia, Sweden), and cellulose (DEAE
Polysaccharides that do not directly bind to haptoglobin, such as cellulose, cellulose (CM-cellulose, AE-cellulose, etc.), which have been given binding ability by treating them with cyanogen bromide, are advantageously used. A method for treating polysaccharides with cyanogen bromide is described by P. Atrecasas, P. and Anfinsen, CB [Methods in Enzymology, ed. by
The affinity chromatography method proposed by Jakoby, WB) pp 345, (1971) has already been established as a method for (insolubilizing) proteins.
同様にして結合基を有しないポリアミド、例え
ばナイロン、ポリアセタール、ポリスチレンなど
の高分子重合体も適当な処理剤例えば臭化シアン
で処理することによつて、ハプトグロビンとの結
合能の基を与えることができる。更に又ガラスの
ような無機材料も、これをアミノアルキルシラン
と処理することによつて、ハプトグロビンと結合
するアミノ基を与えることができ、ハプトグロビ
ンの不溶化に用いることが可能である。 Similarly, polyamides that do not have binding groups, such as high molecular weight polymers such as nylon, polyacetal, and polystyrene, can be treated with a suitable treatment agent such as cyanogen bromide to provide groups capable of binding to haptoglobin. can. Furthermore, inorganic materials such as glass can be treated with aminoalkylsilane to provide amino groups that bind to haptoglobin, and can be used to insolubilize haptoglobin.
ハプトグロビンを物理的又は静電的に吸着させ
て不溶化させる担体としては、ケイソウ土、活性
炭などの外、DEAE−セフアデツクス、DEAE−
セルロースなどのイオン交換体などが挙げられ
る。又ハプトグロビンを不溶化する架橋剤として
は、例えばグルタールアルデヒドのような二官能
性化合物を用いることができる。 Examples of carriers that physically or electrostatically adsorb haptoglobin to insolubilize it include diatomaceous earth, activated carbon, DEAE-Sephadex, DEAE-
Examples include ion exchangers such as cellulose. Further, as a crosslinking agent for insolubilizing haptoglobin, a bifunctional compound such as glutaraldehyde can be used.
酵素を閉じ込めて不溶化させるのに用いられる
マトリツクスは、高分子量の有機重合体のゲル又
は繊維が用いられるが、ハプトグロビンについて
も適当な手段を選ぶことによつて、これらが用い
られ得る。例えば単量体の重合の際に、ハプトグ
ロビンが重合系に存在すれば、それは生成重合体
ゲル中に閉じ込められる。 The matrix used to trap and insolubilize the enzyme is a gel or fiber of a high molecular weight organic polymer, and these can also be used for haptoglobin by selecting an appropriate means. For example, during monomer polymerization, if haptoglobin is present in the polymerization system, it becomes entrapped in the resulting polymer gel.
担体にタンパク結合可能基を与える処理剤で処
理する条件は次のとおりである。 The conditions for treating the carrier with a treatment agent that provides a protein-binding group are as follows.
多糖類担体の場合、通常臭化シアンを用い、
PH10〜12、で冷却しながら行う。 In the case of polysaccharide carriers, cyanogen bromide is usually used;
Do this while cooling at pH 10-12.
高分子重合体である巨大網状構造を有するメ
タアクリレート重合体も又同様にして、PH10〜
12で臭化シアンで活性化するとよい結果が得ら
れる。 A methacrylate polymer having a large network structure, which is a high molecular weight polymer, can also be used in the same manner.
Activation with cyanogen bromide at 12 gives good results.
無機質担体であるガラスの活性化は、オルガ
ノシランによつて行われる。その条件として
は、不活性溶媒にオルガノシランを溶かし、室
温で十分な時間反応させることによつて得られ
る。 Activation of the inorganic carrier glass is carried out with organosilanes. The conditions are such that organosilane is dissolved in an inert solvent and reacted at room temperature for a sufficient period of time.
重合体−トラツプ法としては、ハプトグロビ
ンを吸着する担体はすべて可能であるが、より
簡便な担体が好ましい。例えばDEAE−セルロ
ースは、蒸留水で十分に洗浄し、温度を室温に
保つてかきまぜることによつてハプトグロビと
結合させ、このハプトグロビン結合担体は、次
いで2次的担体でもつて重合化させ得る。 For the polymer-trap method, any carrier capable of adsorbing haptoglobin can be used, but simpler carriers are preferred. For example, DEAE-cellulose can be bound to haptoglobin by thorough washing with distilled water and stirring while maintaining the temperature at room temperature, and this haptoglobin-binding carrier can then be polymerized with a secondary carrier.
以上のようにして得られた結合能を有する担体
とハプトグロビンとの反応は、中性付近(PH6〜
8)で約3〜25℃で行うことができる。 The reaction between the carrier having binding ability obtained as described above and haptoglobin occurs at around neutrality (PH6~
8) can be carried out at about 3 to 25°C.
このようにして得た固定化Hpは、ヘモグロビ
ン測定用キツトとして使用するために適当な装置
にセツトする。装置は、筒状あるいは平板状であ
り、筒状の場合適当な材質の筒内に一定量の固定
化Hpをセツトしキツトを形成する。平板状の場
合、紙又はガラス、プラスチツクその他適当な平
板に一定の厚さをもつて固定化Hpをセツトす
る。 The immobilized Hp thus obtained is set in a suitable device for use as a hemoglobin measurement kit. The device has a cylindrical shape or a flat plate shape, and in the case of a cylindrical shape, a certain amount of immobilized Hp is set in a cylinder made of a suitable material to form a kit. In the case of a flat plate, the immobilized Hp is set on a paper, glass, plastic or other suitable flat plate to a certain thickness.
セツトされる固定化Hpの粒子径は40〜200μで
均一化したものが使用される。 The particle diameter of the immobilized Hp to be set is 40 to 200μ and is used.
固定化Hpの装置へのセツト量は、筒状の場合
体積量として0.5〜70cm3、筒の長さ2〜20cm好ま
しくは、4〜10cmが一般的に良好なキツトを提供
する。平板の場合は、厚さ0.5〜5mm体積として
0.5〜6cm3がよい。セツト量の目安としては、内
径1.5cm長さ10cmの筒状装置に固定化Hpを充填し
た場合、約5〜100mgのヘモグロビンを結合す
る。 The amount of immobilized Hp set in the apparatus is generally 0.5 to 70 cm 3 in volume in the case of a cylindrical kit, and the length of the cylinder is 2 to 20 cm, preferably 4 to 10 cm, to provide a generally good kit. In the case of a flat plate, the thickness is 0.5 to 5 mm.
0.5~ 6cm3 is good. As a guideline for the set amount, when a cylindrical device with an inner diameter of 1.5 cm and a length of 10 cm is filled with immobilized Hp, about 5 to 100 mg of hemoglobin will be bound.
このようにセツトされた固定化Hpからなるキ
ツトは、あらかじめその固定化Hpのセツト量と
ヘモグロビン量との検量線を求め相応する量目を
例えば濃度として装置に付置せしめる。 The kit consisting of the immobilized Hp set in this manner is placed in the apparatus by determining in advance a calibration curve between the set amount of immobilized Hp and the amount of hemoglobin, and setting the corresponding amount, for example, concentration.
キツトによるヘモグロビン量の測定は、固定化
Hpに吸着し、赤色に着色した部分の長さ又は体
積を測定することにより、試料中の遊離ヘモグロ
ビン量を検量線から求める。 Measurement of hemoglobin amount using a fixed kit
The amount of free hemoglobin in the sample is determined from the calibration curve by measuring the length or volume of the part that is adsorbed to Hp and colored red.
試料とキツトとの反応条件は特に限定されるも
のではないが、PH5〜8の低塩濃度(0.05〜
0.3M)の水溶液で湿潤させた後、試料を注加
し、展開によつて結合させる。要する時間は、約
5分間〜20分間で十分である。十分の浸透後キツ
ト容量の2倍以上の水溶液で洗浄する。洗浄液
は、PH5〜8の低塩濃度の水溶液であれば特に限
定されない。 The reaction conditions between the sample and the kit are not particularly limited, but include a low salt concentration (0.05 to 8) with a pH of 5 to 8.
After wetting with an aqueous solution of 0.3M), the sample is added and bonded by development. The time required is approximately 5 minutes to 20 minutes. After sufficient penetration, wash with an aqueous solution of at least twice the volume of the kit. The cleaning liquid is not particularly limited as long as it is an aqueous solution with a low salt concentration of pH 5 to 8.
キツトの再生方法は、測定完了後のキツトを1
〜5Mグアニジン・HCl(PH4〜6)、0.05〜0.5M
グリシン・HCl(PH2〜3)、0.05〜0.5M
Na2HPO4・NaOH(PH10〜11)、1〜5M NaBr又
は1〜6M MgCl2(PH3〜5)の水溶液と接触さ
せHpとヘモグロビンの結合を解きヘモグロビン
を遊離させる。その後低塩濃度のPH5〜8の水溶
液で洗浄後、再び使用に供せうる。 To regenerate the kit, after the measurement is completed,
~5M guanidine/HCl (PH4~6), 0.05~0.5M
Glycine/HCl (PH2~3), 0.05~0.5M
It is brought into contact with an aqueous solution of Na 2 HPO 4 .NaOH (PH 10-11), 1-5 M NaBr or 1-6 M MgCl 2 (PH 3-5) to break the bond between Hp and hemoglobin and liberate hemoglobin. Thereafter, it can be used again after washing with an aqueous solution of pH 5 to 8 with a low salt concentration.
キツトの保存は、乾燥状態あるいは防腐剤(例
えば0.1%NaN3)を含有したPH5〜8の低塩濃度
水溶液中に保持する。温度は低温好ましくは10℃
以下凍結しない条件である。水溶液中での保存
は、約2年間は活性の低下なく使用できる。 The kit is stored in a dry state or in a low salt concentration aqueous solution with a pH of 5 to 8 containing a preservative (eg, 0.1% NaN 3 ). Temperature is low, preferably 10℃
Below are the conditions for not freezing. When stored in an aqueous solution, it can be used for about 2 years without loss of activity.
測定に際して、試料が血清、血漿、尿、髄液等
の場合は、何等前処理をおこなうことなしにその
まま使用可能である。 For measurement, if the sample is serum, plasma, urine, cerebrospinal fluid, etc., it can be used as is without any pretreatment.
かくして提供されたヘモグロビン測定キツト
は、遊離のヘモグロビン量を簡単且つ迅速に分別
定量できる試薬である。 The hemoglobin measurement kit thus provided is a reagent that can easily and quickly separate and quantify the amount of free hemoglobin.
以下に実施例を示すが、本発明は何等これに限
定されない。 Examples are shown below, but the present invention is not limited thereto in any way.
実施例 1
プール人血漿より精製して得たHpを臭化シア
ン法でSepharose4Bに固定し、これを内径1.5cm
長さ10cmの注射筒に充填し、充填物の上面が乱れ
ない様円形に切つた紙を充填物の上面に載せ生
理的食塩液で湿潤させキツトを作成した。このキ
ツトの遊離ヘモグロビンの検量線は図1の如く直
線的である。Example 1 Hp obtained by purification from pooled human plasma was fixed on Sepharose 4B using the cyanogen bromide method, and this was fixed on Sepharose 4B with an inner diameter of 1.5 cm.
A syringe with a length of 10 cm was filled with the mixture, and a paper cut into a circle was placed on the top of the filling so that the top surface of the filling would not be disturbed, and a kit was made by moistening it with physiological saline. The free hemoglobin calibration curve of this kit is linear as shown in FIG.
実施例 2
内径1.5cm長さ10cmおよび内径1cm長さ10cmの
2種類の透明なプラスチツクチユーブの底面をグ
ラスフイルター(600メツシユ)で固定しこれら
に実施例1と同様にして作成した固定化Hpをそ
れぞれ高さ7cmに充填したのち同種のグラスフイ
ルターを内容物上面に固定し、その上に少量の生
理的食塩水を充填してカラムの上下両端をゴムキ
ヤツプで封じた装置をそれぞれ100個ずつ計400個
作成した。これらのうち内径1.5cmのカラムに固
定化Hpを充填した装置10個を選び、標準ヘモグ
ロビンをヘモグロビンを含まない血清に溶解した
1mg/ml溶液を2ml通過させた。赤色に着色した
部分の長さは最高1.85cm、最低1.70cm、平均1.75
cmであつた。Example 2 The bottom surfaces of two types of transparent plastic tubes, one with an inner diameter of 1.5 cm and a length of 10 cm and an inner diameter of 1 cm and a length of 10 cm, were fixed with a glass filter (600 mesh), and the immobilized Hp prepared in the same manner as in Example 1 was applied to these tubes. After filling each column to a height of 7 cm, a glass filter of the same type was fixed on top of the contents, a small amount of physiological saline was filled on top of the column, and both ends of the column were sealed with rubber caps, 100 each for a total of 400 units. I created one. Of these, 10 devices were selected in which columns with an inner diameter of 1.5 cm were filled with immobilized Hp, and 2 ml of a 1 mg/ml solution of standard hemoglobin dissolved in hemoglobin-free serum was passed through them. The maximum length of the red colored part is 1.85 cm, the minimum length is 1.70 cm, and the average length is 1.75 cm.
It was cm.
実施例 3
多孔性ガラス(孔直径約80μ、ガラス直径100
メツシユ)をガンマー−アミノプロピル−トリエ
トキシシランで活性化させたのち、別にウマの血
漿を原料に精製して得たHpをこの多孔性ガラス
に固定した。これを実施例2と同様にしてプラス
チツクチユーブに充填した装置を作成した。これ
らのうち10個を選び、標準ヘモグロビンをヘモグ
ロビンを含まない血清に溶解した1mg/ml溶液を
2ml通過させたところ、赤色に着色した部分の長
さは最高2.63cm、最低2.47cm、平均2.56cmであつ
た。Example 3 Porous glass (pore diameter approximately 80μ, glass diameter 100μ)
After activating Hp with gamma-aminopropyl-triethoxysilane, Hp obtained by separately purifying horse plasma as a raw material was immobilized on this porous glass. A device was prepared by filling a plastic tube with this in the same manner as in Example 2. When 10 of these were selected and 2 ml of a 1 mg/ml solution of standard hemoglobin dissolved in hemoglobin-free serum was passed through them, the length of the red colored part was 2.63 cm at the highest, 2.47 cm at the lowest, and 2.56 cm on average. It was hot.
実施例 4
スライドグラフの平板(3×3cm)に、臭化シ
アン法によつてセフアローズに固定化したHpを
1mmの厚さで均一にセツトし、ヘモグロビン測定
用キツトとした。Example 4 Hp immobilized on Sepharose by the cyanogen bromide method was uniformly set on a slide graph plate (3 x 3 cm) to a thickness of 1 mm to prepare a hemoglobin measurement kit.
実施例 5
フイルターペーパー(2×10cm)に臭化シアン
法によつてセフアローズに固定化したHpを2mm
の厚さで均一にセツトし、ヘモグロビン測定用キ
ツトとした。Example 5 2 mm of Hp immobilized on Cepharose by the cyanogen bromide method was placed on a filter paper (2 x 10 cm).
A kit for hemoglobin measurement was prepared.
図1は実施例1により得られた、本発明の方法
およびキツトを使用した遊離ヘモグロビンの測定
検量線を示す。
FIG. 1 shows a calibration curve for measuring free hemoglobin using the method and kit of the present invention, obtained in Example 1.
Claims (1)
ビン測定試薬。 2 固定化ハプトグロビンを筒状の装置にセツト
してなる特許請求の範囲第1項の遊離ヘモグロビ
ン測定試薬。 3 固定化ハプトグロビンを平板状にセツトして
なる特許請求の範囲第1項の遊離ヘモグロビン測
定試薬。[Claims] 1. A reagent for measuring free hemoglobin comprising immobilized haptoglobin. 2. The reagent for measuring free hemoglobin according to claim 1, which comprises immobilized haptoglobin set in a cylindrical device. 3. The reagent for measuring free hemoglobin according to claim 1, which comprises immobilized haptoglobin set in a flat plate shape.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5860178A JPS54150885A (en) | 1978-05-17 | 1978-05-17 | Hemoglobin measuring kit |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5860178A JPS54150885A (en) | 1978-05-17 | 1978-05-17 | Hemoglobin measuring kit |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS54150885A JPS54150885A (en) | 1979-11-27 |
| JPS6113184B2 true JPS6113184B2 (en) | 1986-04-11 |
Family
ID=13089023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5860178A Granted JPS54150885A (en) | 1978-05-17 | 1978-05-17 | Hemoglobin measuring kit |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS54150885A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5456835A (en) * | 1993-11-08 | 1995-10-10 | Hemasure, Inc. | Device and process for removing free hemoglobin from blood |
-
1978
- 1978-05-17 JP JP5860178A patent/JPS54150885A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS54150885A (en) | 1979-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1321768C (en) | Enzyme immobilization and bioaffinity separations with perfluorocarbon polymer-based supports | |
| JPS645010B2 (en) | ||
| AU727699B2 (en) | Patient-specific immunoadsorbers for the extracorporeal apheresis and methods for their preparation | |
| JP4945876B2 (en) | High mobility group protein adsorbent and body fluid purification column | |
| CA1085291A (en) | Fixed haptoglobin preparations | |
| JPS6128375B2 (en) | ||
| JPS6114466B2 (en) | ||
| JPS6113184B2 (en) | ||
| JPS6027517B2 (en) | Method for immobilizing proteins by polymerizing on the spot | |
| EP0233620B1 (en) | Use of an adsorbent for purification of blood coagulation factor viii | |
| JPS6113185B2 (en) | ||
| JPS6155415B2 (en) | ||
| JPS62181296A (en) | Separation of anti-viii : c antibody | |
| JPS6141608B2 (en) | ||
| JPH09504532A (en) | Chromatographic method for producing virus inactivated fraction containing factor VIII | |
| RU2366958C2 (en) | Method of blood purification from thyroid hormone antibodies by means of immobilised magnetic agent | |
| JP3157026B2 (en) | Adsorbent for blood purification | |
| RU2098140C1 (en) | Method of extracorporal immunosorption carrying out | |
| JPH05271299A (en) | Protein a-immobilized adsorbent | |
| JPH0456807B2 (en) | ||
| Toomik et al. | Preparation of ferric adsorbent paper and its interaction with phosphate-containing biomolecules | |
| SU883053A1 (en) | Immunosorbent | |
| JPH05271300A (en) | Protein g-immobilized adsorbent | |
| Sato et al. | Effect of pore size of porous bead carriers immobilizing antibody on IgE adsorption | |
| SU979508A1 (en) | Process for preparing immobilized plasminogene |